Factors Determining Outcomes of Aortic Valve Surgery in Patients with Aortic Regurgitation Due to Behçet’s Disease: Impact of Preoperative Echocardiographic Features




Background


Paravalvular leakage after open heart surgery is notoriously common in patients with aortic regurgitation (AR) due to Behçet’s disease. The aim of this study was to test whether initial echocardiographic findings are useful to predict recurrent AR.


Methods


Lesion severity on preoperative echocardiography was scored for redundant aortic valve cusp (0–2 points), aortic pseudoaneurysm (0–2 points), and dissection of the adjacent interventricular septum (0–2 points) in 22 patients with severe AR due to Behçet’s disease (13 men; mean age, 42.4 ± 11.5 years), which was confirmed by histologic examination after open heart surgery.


Results


Recurrent AR developed in 13 patients at a median of 12.6 months (range, 2.4–70.3 months) after the first operation, and 10, four, and one patient underwent second, third, and fourth surgery, respectively, to control recurrent AR; three patients died. Those patients with recurrent AR had a significantly higher incidence of repeat surgery or death (84.6% [11 of 13] vs 0%, P = .015). Multivariate analysis showed that perioperative immunotherapy (hazard ratio, 0.002; 95% confidence interval, 0.001–0.1761; P = .006) and total echocardiographic score (hazard ratio, 2.843; 95% confidence interval, 1.350–5.991; P = .006) were independent factors associated with recurrent AR. The 1-year, 3-year, and 5-year AR-free survival rates were 73 ± 10%, 46 ± 12%, and 39 ± 12%. The optimal cutoff value for total echocardiographic score was 3.0, and the 5-year AR-free survival rates were significantly lower in patients with scores ≥ 3 (20 ± 13% vs 50 ± 19%, P = .022).


Conclusions


This retrospective study confirms that initial echocardiographic features can provide useful prognostic information in patients with AR due to Behçet’s disease.


Behçet’s disease (BD) is an idiopathic chronic inflammatory disorder characterized by the involvement of large and small arteries, as well as the variable involvement of several organs. BD involving the heart is reported to be rare and to show various clinical manifestations, including endomyocardial fibrosis, mural thrombi, active valvulitis, and vasculitis involving the pulmonary artery or aorta. Aortic regurgitation (AR) is the most important clinical presentation of cardiac BD, because it is challenging both to diagnose and to treat. Although the diagnostic criteria proposed by the International Study Group for Behçet’s Disease (ISG) include a requirement for mucocutaneous manifestations, these are not commonly observed in patients with severe acute AR due to BD. These criteria frequently lead to misdiagnosis or delay in adequate treatment. Moreover, patients with AR due to BD have a notoriously high incidence of recurrent AR after initial successful corrective surgery, often developing postoperative dehiscence or pseudoaneurysm, which are associated with poor long-term event-free survival. Outcomes may be improved by early diagnosis on the basis of characteristic echocardiographic features and/or pathologic findings, followed by aggressive surgical debridement of the aortic root and postoperative immunosuppressive therapy. These suggestions, however, were based on limited clinical experience without adequate statistical analysis. Thus, prognostic factors associated with outcomes of patients with AR due to BD remain to be determined. We hypothesized that careful analysis of initial echocardiographic manifestations may provide valuable prognostic information on patients with AR due to BD. We tested our hypothesis by developing an echocardiographic scoring system to assess initial lesion severity and determining whether this scoring system could predict surgical or clinical outcomes.


Methods


Subjects


For this retrospective study, we reviewed a prospective registry of patients with BD evaluated at the Asan Medical Center (Seoul, Korea) from 1995 to 2007, and we enrolled patients who underwent open heart surgery to correct severe AR due to BD. Patients were diagnosed on the basis of clinical findings, including echocardiographic and pathologic results. Patients who did not fulfill the current ISG criteria for BD were diagnosed on the basis of the consensus determinations of a cardiologist (J.-K.S.), a rheumatologist (B.Y.), and a pathologist (I.L.), and final diagnosis was principally dependent on characteristic histologic findings of the excised aortic valve and aorta. Our study cohort consisted of 22 patients with severe AR due to BD. We have published clinical data of patients admitted until 2005 elsewhere, and the number of subjects in this study is more than two times that in the last study.


Echocardiography


All patients underwent comprehensive two-dimensional and Doppler echocardiography before initial surgery. During both transthoracic and transesophageal echocardiography, special attention was paid to the detailed evaluation of individual aortic cusps, the ascending aorta, the left ventricular outflow tract, and the interventricular septum adjacent to the aortic leaflets. Using high-resolution transesophageal echocardiographic images, patients were scored semiquantitatively (0–2) on the basis of the degree of BD involvement in three different anatomic lesions (aortic cusp, aortic pseudoaneurysm, and dissection into the adjacent interventricular septum). Aortic cusp involvement included either aneurysmal changes with redundant motion of a single cusp (grade 1; Figure 1 A, Video 1 A; view video clip online) or aneurysmal changes of more than two cusps resulting in the formation of a conglomerated mass (grade 2; Figure 1 B, Video 1 B; view video clip online). The degree of aortitis involving the ascending aorta was graded on the basis of the size of the pseudoaneurysm or echo-free space; if it was confined to one aortic cusp or the sinus of Valsalva, it was graded as 1 ( Figure 1 C, Video 1 C; view video clip online), whereas if it was large enough to extend to the sinotubular junction, it was graded as 2 ( Figure 1 D, Video 1 D; view video clip online). Grading of the dissection of the adjacent interventricular septum was based on its maximal length, with dissections < 1 cm graded as 1 ( Figures 2 A and 2 B, Videos 2 A and 2 B; view video clip online), and those ≥1 cm were graded as 2 ( Figures 2 C and 2 D, Videos 2 C and 2 D; view video clip online). The sum of the scores of each of these three criteria was used to represent the degree of BD involvement in each patient, with 6 being the maximum total score allowed ( Table 1 ).




Figure 1


Representative transesophageal echocardiograms showing a scoring system for BD involvement of the aortic cusp (A,B) and the ascending aorta (C,D) . Aortic cusp involvement could include either aneurysmal change with redundant motion of a single cusp (A) (grade 1) or aneurysmal changes of more than two cusps resulting in the formation of a conglomerated mass (B) (grade 2). A pseudoaneurysm or echo-free space extending beyond the sinotubular junction was graded as 2 (D) , whereas a lesion confined to one aortic cusp or the sinus of Valsalva was graded as 1 (C) . Ao , Aorta; LA , left atrium; LV , left ventricle; PA , pulmonary artery. See Videos 1 A, 1 B, 1 C, and 1 D.



Figure 2


Representative transesophageal echocardiograms showing a scoring system for BD involvement of the adjacent interventricular septum (IVS) at systole (A,C) and diastole (B,D) . Dissection of the adjacent IVS was graded depending on the maximal length of the dissection: dissections < 1 cm were graded as 1 (A,B) , and those ≥1 cm were graded as 2 (C,D) . Ao , Aorta; LA , left atrium; LV , left ventricle. See Videos 2 A, 2 B, 2 C, and 2 D.


Table 1

A proposed scoring system for echocardiographic features of AR due to BD
























Lesion site Score 0 Score 1 Score 2
Aortic cusp Normal Aneurysmal change and redundant motion involving one cusp Involving more than one cusp and forming a conglomerated mass
Ascending aorta Normal Pseudoaneurysm or echo-free space confined to one aortic cusp in short-axis view or up to the sinotubular junction in long-axis view Pseudoaneurysm or echo-free space surrounding at least two cusps or extending up to the tubular portion of the aorta
Interventricular septum Normal Minimal dissection into the adjacent septum (maximal length < 1cm) Maximal length of the dissection ≥ 1 cm


Follow-Up Data


All patients underwent surgical intervention to control severe AR. The timing of surgery and the perioperative administration of anti-inflammatory drugs were determined by the attending physician after consultation with cardiac surgeons and rheumatologists. Immunosuppressive drugs included oral prednisolone (1 mg/kg/day), colchicines (1.2 mg/day), azathioprine (1–2 mg/kg/day), methotrexate (15 mg/week), and cyclophosphamide (2 mg/day). Blood concentration of C-reactive protein, erythrocyte sedimentation rate, and clinical evaluation were used to titrate these drugs. The type of surgery was also determined by a cardiac surgeon. Pathologic examination of the surgical specimens showed aortic valvulitis with fibrinous deposits, microabscesses, and extensive endothelial loss, with no evidence of microorganism or infective endocarditis, characteristics compatible with the involvement of BD. During repeat cardiac surgery, every effort was made to aggressively debride the native aortic root, with wide reconstruction using a valved conduit or aortic graft. Patients underwent regular echocardiographic follow-up every 6 or 12 months, depending on each patient’s condition.


Follow-up data through September 2009 were obtained for all patients through telephone interviews and retrospective review of findings from regular outpatient visits. Adverse events included repeat surgery for recurrent AR and cardiac death.


Statistical Analysis


Numerical variables are expressed as mean ± SD. Clinical variables were compared in patients who did and those who did not develop recurrent AR after the first operation. Between-group comparisons were performed using the Mann-Whitney U test or the Kruskal-Wallis test as appropriate. Nominal variables were compared using Fisher’s exact test. Variables with P values ≤ .10 were selected for multivariate analysis. A Cox proportional-hazards model using a backward stepwise selection process was used to determine parameters associated with development of recurrent AR after the first operation. Cumulative survival rate curves were generated using the Kaplan-Meier method and compared using the log-rank test. Receiver operating characteristic curve analysis was used to assess the optimal cutoff point for total echocardiographic score for predicting AR recurrence; the optimal cutoff value was defined as the value that gave the maximal sum of sensitivity and specificity. All P values were two sided, and P values < .05 were considered significant. All statistical analyses were performed using SPSS version 12.0 (SPSS, Inc., Chicago, IL).




Results


Our study cohort consisted of 22 patients (13 men, 9 women; mean age, 42.4 ± 11.5 years); their clinical and demographic data are summarized in Table 2 . Seven patients (patients 1, 6, 16, 17, 19, 21, and 22) had been receiving treatment after confirmatory diagnosis of extracardiac BD; of these, four (patients 16, 17, 19, and 22) developed symptomatic AR, whereas asymptomatic severe AR was detected in the other three patients during regular follow-up. The remaining 15 patients presented with sudden congestive heart failure due to severe AR. Although 19 patients (all except patients 7, 12, and 20) had histories of recurrent oral ulceration at the time of AR diagnosis, only eight patients fulfilled current ISG criteria at the time of AR diagnosis. Using the criteria of the Japan Behçet’s Disease Research Committee, no patient was classified as having the “complete” subtype. Rather, nine (patients 1, 5, 6, 13, 16, 17, 18, 21, and 22) were classified as having the “incomplete” subtype and nine (patients 2, 3, 4, 8, 9, 11, 14, 15, and 19) as having the “suspected” subtype, with the remaining four patients (patients 7, 10, 12, and 20) not diagnosed with BD. During follow-up, three additional patients (patients 2, 3, and 14) fulfilled the ISG criteria.



Table 2

Baseline clinical data

















































































































































































































































































































Patient Age/sex Oral ulcer Acute AR ISG criteria Echocardiographic score First operation Immunotherapy Recurrent AR
AV Ao IVS Total
1 36/F Yes No Yes 2 1 0 3 AVR-Me (3/1996) No Yes
2 34/M Yes Yes No 2 2 1 5 AVR-Me (2/1997) No Yes
3 36/M Yes Yes No 1 1 0 2 AVR-Me (7/1997) No Yes
4 23/F Yes Yes No 1 1 0 2 AVR-T (6/1998) No Yes
5 40/F Yes Yes Yes 1 2 2 5 AVR-Me (5/1999) No Yes
6 45/M Yes No No 0 2 0 2 Root repair (2/2000) Preoperative (P + C) Yes
7 38/M No Yes No 2 1 1 4 Bentall-H (9/2001) Preoperative (P) Yes
8 53/M Yes Yes No 2 1 0 3 Bentall-T (1/2002) Preoperative (P) No
9 32/M Yes Yes Yes 1 1 0 2 Bentall-M (2/2002) Preoperative (P) No
10 46/M Yes Yes No 2 0 2 4 Bentall-M (4/2002) Postoperative (P) Yes, mild
11 49/M Yes Yes No 1 0 0 1 AVR-Me (5/2004) Preoperative (P + C) No
12 72/M No Yes No 2 1 0 3 AVR-T (3/2006) N Yes, mild
13 44/F Yes Yes Yes 2 1 2 5 Bentall-H (6/2006) Preoperative (P + C) Yes
14 61/F Yes Yes No 1 0 0 1 AVR-T (7/2000) Postoperative (P + C) No
15 23/M Yes Yes No 1 2 0 3 AVR-Me (8/2004) Postoperative (P + A) Yes, mild
16 37/F Yes Yes Yes 2 0 0 2 Bentall-H (7/2007) Postoperative (P + A + C) No
17 36/M Yes Yes No 1 2 0 3 Bentall-H (9/2005) Postoperative (P + C) Yes
18 49/M Yes Yes Yes 1 0 0 1 Bentall-M (10/2007) Preoperative (P + C) No
19 43/M Yes Yes No 1 0 0 1 AVR-Me (5/2007) Preoperative (P) No
20 48/F No Yes No 1 0 0 1 Bentall-M (2/2008) Postoperative (P + C) No
21 35/F Yes No Yes 1 0 0 1 Bentall-H (2/2005) Preoperative (P + C) Yes
22 54/F Yes Yes Yes 1 0 0 1 Bentall-H (12/2008) Preoperative (P + C) No

A , Azathioprine; Ao , aorta; AV , aortic valve; AVR , aortic valve replacement; C , colchicine; F , female; H , homograft; IVS , interventricular septum; M , male; Me , mechanical; P , prednisolone; T , tissue valve.


All 22 patients showed severe AR on initial echocardiography, with a mean echocardiographic score of 2.5 ± 1.4. Sixteen patients (72.7%) received perioperative immunotherapy at the time of the first operation, whereas the remaining six patients, most of whom were treated during the early part of the study period, underwent aortic valve surgery in the absence of an accurate diagnosis. The first two patients (patients 1 and 2) were treated with antibiotics because of presumptive diagnoses of culture-negative infective endocarditis. Four patients were started on immunotherapy after confirmation of paravalvular leakage, three (patients 2, 3, and 12) after the first operation and one (patient 5) after a second operation.


After a median follow-up period of 46 months (range, 12.6–149.6 months; interquartile range, 66.7 months), the 22 patients had undergone 37 operations, with 10, four, and one patient undergoing second, third, and fourth operations, respectively ( Figure 3 ). After wide debridement, 10 patients underwent aortic valve replacement and 11 underwent the Bentall operation using a valved conduit. One patient (patient 2), who was diagnosed with an aortic pseudoaneurysm alone, underwent aortic graft replacement with aortic valve repair. There were no operation-related deaths, and predischarge echocardiography showed well-functioning prostheses without pathologic regurgitation. However, 13 patients developed recurrent AR at a median 12.6 months (range, 2.4–70.3 months) after the first operation; their clinical outcomes are summarized in Table 3 .




Figure 3


Summary of the clinical outcomes of patients with AR due to BD.


Table 3

Follow-up data for patients who developed recurrent AR after the first operation




















































































































Patient Immunotherapy Second operation Recurrent AR Immunotherapy Third operation Final results
1 No Bentall (6/1996) Yes No Bentall (6/1997) Died during third operation
2 Yes (P + C) AVR (8/1997) Yes Yes (P + C) Bentall (12/2001) Survived after third operation
3 Yes (P + C) Bentall (12/1997) No Yes (P + C) Not done Survived after second operation
4 No AVR (6/2005) No No Not done Survived after second operation
5 No AVR (7/1999) Yes Yes (P) AVR (5/2000) Died during fourth operation (12/2001)
6 Yes (P + C) AVR (11/2003) No Yes (P + C) Not done Survived after second operation
7 Yes (P) AVR (1/2008) No Yes (P) Not done Survived after second operation
10 Yes (C + A) Not done Stable with minimal AR
12 Yes (P) Not done Stable with minimal AR
13 Yes (P + C + M) AVR (12/2007) Yes Yes (P + Ch) Transplantation (1/2009) Survived after transplantation
15 Yes (P + A) Not done Sudden death due to rupture of pseudoaneurysm
17 Yes (P + A + C) AVR (5/2007) No Survived after second operation
21 Yes (P + M + C) Bentall (6/2009) No Survived after second operation

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jun 11, 2018 | Posted by in CARDIOLOGY | Comments Off on Factors Determining Outcomes of Aortic Valve Surgery in Patients with Aortic Regurgitation Due to Behçet’s Disease: Impact of Preoperative Echocardiographic Features

Full access? Get Clinical Tree

Get Clinical Tree app for offline access